Retrospective studies demonstrated reduced COPD exacerbations in T2DM patients on GLP-1RAs, as compared to DPP-4 inhibitors and sulfonylureas [9, 79]
In addition, GLP-1s slow stomach emptying, meaning that less glucose from food is released into the bloodstream
This helps your body release insulin when glucose is high, reduces glucagon, slows stomach emptying, and can lower appetite
This code covers the act of the injection itself, whether it is done through an intramuscular (IM) or subcutaneous (SubQ) route
Obesity (Silver Spring, Md.), 10.1002/oby.24336
(2001) The role of the insulin-like growth factor-I receptor in cancer Annual Review of Medicine 52:108123